Aspirin and cancer risk: a quantitative review to 2011.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annals of Oncology

• Publication date

  2012-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/annonc/mds113PMID 22517822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials.

  2012cited by this paper
• Aspirin use and risk for lung cancer: a meta-analysis.

  2011cited by this paper
• Long‐term aspirin use and the risk of total, high‐grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988–2006

  2011cited by this paper
• Aspirin and cancer: has aspirin been overlooked as an adjuvant therapy?

  2011cited by this paper
• Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype

  2011cited by this paper
• Use of Non-Steroidal Anti-Inflammatory Drugs and Prostate Cancer Risk: A Population-Based Nested Case-Control Study

  2011cited by this paper
• Aspirin use and breast cancer risk: a meta-analysis

  2011influential reference
• Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.

  2011influential reference
• The epidemiology of renal cell carcinoma.

  2011cited by this paper
• Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

  2011cited by this paper
• Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study

  2011cited by this paper
• Regular aspirin use and breast cancer risk in US Black Women

  2011cited by this paper
• Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.

  2010cited by this paper
• Use of nonsteroidal anti‐inflammatory drugs and prostate cancer risk: A meta‐analysis

  2010cited by this paper
• Aspirin and gastric cancer risk.

  2010cited by this paper
• Nonsteroidal Anti-Inflammatory Drugs and Prostate Cancer Risk in the VITamins And Lifestyle (VITAL) Cohort

  2010cited by this paper
• A Prospective Study of Aspirin Use and the Risk of Gastrointestinal Bleeding in Men

  2010cited by this paper
• Aspirin Use and the Risk of Gastric Cancer: A Meta-Analysis

  2010cited by this paper
• Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study

  2010cited by this paper
• A case-control study of levothyroxine and the risk of colorectal cancer.

  2010cited by this paper
• Effect of aspirin and NSAIDs on risk and survival from colorectal cancer

  2010cited by this paper
• Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II.

  2009cited by this paper
• Nonsteroidal Antiinflammatory Drug Use and Breast Cancer Risk: Subgroup Findings

  2009cited by this paper
• Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement.

  2009cited by this paper
• Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis

  2009influential reference
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study

  2009cited by this paper
• Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.

  2009cited by this paper
• Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis

  2009cited by this paper
• Aspirin, salicylates, and cancer.

  2009cited by this paper
• Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study.

  2009cited by this paper
• Aspirin and folic acid for the prevention of recurrent colorectal adenomas.

  2008cited by this paper
• Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors

  2008cited by this paper
• Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study

  2008cited by this paper
• Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis.

  2008cited by this paper
• Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study

  2008cited by this paper
• Nonsteroidal Anti-inflammatory Drugs and Risk of Esophageal and Gastric Adenocarcinomas in Los Angeles County

  2008cited by this paper
• NSAID use and breast cancer risk in the VITAL cohort

  2008cited by this paper
• Aspirin use and breast cancer risk: a meta‐analysis and meta‐regression of observational studies from 2001 to 2005

  2008cited by this paper
• Protective effect of NSAIDs on cancer and influence of COX-2 C(-765G) genotype.

  2008cited by this paper
• Aspirin dose and duration of use and risk of colorectal cancer in men.

  2008cited by this paper
• Meta‐analysis: the use of non‐steroidal anti‐inflammatory drugs and pancreatic cancer risk for different exposure categories

  2007cited by this paper
• Analgesic and anti-inflammatory drug use and risk of bladder cancer: a population based case control study

  2007cited by this paper
• Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study.

  2007cited by this paper
• Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings.

  2007cited by this paper
• Long-term aspirin use and mortality in women.

  2007cited by this paper
• Inflammation in the Pathogenesis of Chronic Diseases

  2007cited by this paper
• Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies.

  2007cited by this paper
• Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer

  2007cited by this paper
• A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence.

  2007cited by this paper
• Epidemiologic aspects of renal cell carcinoma.

  2006cited by this paper
• Aspirin and the risk of prostate cancer

  2006cited by this paper
• Use of Analgesics and Nonsteroidal Anti-inflammatory Drugs, Genetic Predisposition, and Bladder Cancer Risk in Spain

  2006cited by this paper
• Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials.

  2006cited by this paper
• Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden

  2006cited by this paper
• Nonsteroidal Anti-inflammatory Drugs and Subsite-Specific Colorectal Cancer Incidence in the Iowa Women's Health Study

  2006cited by this paper
• The association between aspirin use and the incidence of colorectal cancer in women.

  2006cited by this paper
• Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort.

  2006cited by this paper
• Aspirin and Nonsteroidal Anti-inflammatory Drug Use and Risk of Pancreatic Cancer: A Meta-analysis

  2006cited by this paper
• Regular Use of Aspirin and Prostate Cancer Risk (United States)

  2006cited by this paper
• Aspirin and cancer risk: an updated quantitative review to 2005

  2006cited by this paper
• Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors

  2006cited by this paper
• Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.

  2005cited by this paper
• A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.

  2005cited by this paper
• Association of Regular Aspirin Use and Breast Cancer Risk

  2005cited by this paper
• Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited.

  2005cited by this paper
• Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

  2005cited by this paper
• Nonsteroidal Anti-inflammatory Drugs and Risk of Prostate Cancer in the Baltimore Longitudinal Study of Aging

  2005cited by this paper
• Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites.

  2005cited by this paper
• Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer.

  2004cited by this paper
• Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway.

  2004cited by this paper
• Aspirin use and mortality from cancer in a prospective cohort study.

  2004cited by this paper
• Risk of breast cancer among users of aspirin and other anti-inflammatory drugs

  2004cited by this paper
• A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

  2003cited by this paper
• Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial.

  2003cited by this paper
• Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.

  2003cited by this paper
• Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer

  2003cited by this paper
• A randomized trial of aspirin to prevent colorectal adenomas.

  2003cited by this paper
• Aspirin and cancer risk: an update to 2001

  2002cited by this paper
• Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.

  2002cited by this paper
• Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US

  2002cited by this paper
• Quantifying heterogeneity in a meta‐analysis

  2002cited by this paper
• Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

  2002cited by this paper
• Cyclo-oxygenase isoenzymes. Structural basis for selective inhibition of cyclo-oxygenases by anti-inflammatory agents.

  2001cited by this paper
• Nonsteroidal anti-inflammatory drug use and breast cancer risk.

  2001cited by this paper
• Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs

  2001cited by this paper
• Non-steroidal anti-inflammatory drugs and bladder cancer prevention

  2000cited by this paper
• Publication bias in meta-analysis: its causes and consequences.

  2000cited by this paper
• Regular use of analgesics is a risk factor for renal cell carcinoma

  1999cited by this paper
• Cyclooxygenase-2 inhibitors in tumorigenesis (part I).

  1998cited by this paper
• Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).

  1998cited by this paper
• Aspirin Use and Colorectal Cancer: Post-Trial Follow-up Data from the Physicians' Health Study

  1998cited by this paper
• Non‐steroidal anti‐inflammatory drugs and prostate cancer progression

  1998cited by this paper
• Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.

  1998cited by this paper
• Drugs and colon cancer

  1998cited by this paper
• Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma

  1998cited by this paper
• Cyclo-Oxygenase Isoenzymes

  1997cited by this paper
• Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

  1997cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Epidemiology of renal-cell carcinoma.

  1997cited by this paper

• The Anti-Metastatic Role of Aspirin in Cancer: A Systematic Review

  2026cites this paper
• The unseen architects of metastasis: coagulation factors in pre-metastatic niche development.

  2026cites this paper
• Low-Dose Aspirin for Individualized Cancer Prevention in Older Adults: A Secondary Analysis of the ASPREE Randomized Clinical Trial.

  2025cites this paper
• Pancreatic cancer risk prediction using deep sequential modeling of longitudinal diagnostic and medication records

  2025cites this paper
• The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC.

  2025cites this paper
• Bioinformatics Based Drug Repurposing Approach for Breast and Gynecological Cancers: RECQL4/FAM13C Genes Address Common Hub Genes and Drugs

  2025cites this paper
• Non-Randomized Controlled Trial Comparing Response of Rectal Cancer Chemoradiation with and without Low-Dose Aspirin

  2025cites this paper
• Chemoprevention of Gastrointestinal Cancers: An Umbrella Review of Meta‐Analyses of Randomized Controlled Trials and Cohort Studies

  2025cites this paper
• Association between sulfur microbial diet and the risk of esophageal cancer: a prospective cohort study in 101,752 American adults

  2024cites this paper
• Effectiveness of long-term low-dose aspirin in the prevention of gastric cancer after Helicobacter pylori eradication: study design and rationale of Ardabil gastric cancer randomized placebo-controlled prevention trial (AGCPT)

  2024cites this paper
• Assessment of the frequency and risk factors for colorectal cancer in acromegaly

  2024cites this paper
• Aspirin but not statins is inversely related to gastric cancer with a duration–risk effect: Results from the Stomach Cancer Pooling Project Consortium

  2024cites this paper
• DDIT4 Downregulation by siRNA Approach Increases the Activity of Proteins Regulating Fatty Acid Metabolism upon Aspirin Treatment in Human Breast Cancer Cells

  2023cites this paper
• Cancer Progress and Priorities: Gastric Cancer.

  2023cites this paper
• Does Therapeutic Repurposing in Cancer Meet the Expectations of Having Drugs at a Lower Price?

  2023cites this paper
• Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women

  2023cites this paper
• Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses

  2023cites this paper
• Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer

  2023cites this paper
• Inflammatory cytokine‐enriched microenvironment plays key roles in the development of breast cancers

  2023cites this paper
• Modulation of diverse oncogenic signaling pathways by oroxylin A: An important strategy for both cancer prevention and treatment.

  2022cites this paper
• Clinical Study of Aspirin and Zileuton on Biomarkers of Tobacco-Related Carcinogenesis in Current Smokers

  2022cites this paper
• The importance of long-term follow up of participants in clinical trials

  2022cites this paper
• Meta-analysis of aspirin-guided therapy of colorectal cancer

  2022cites this paper
• Primary Care Clinicians, Cancer Survivorship, and Lifestyle Medicine.

  2022cites this paper
• Recent Developments on Synthesis Strategies, SAR Studies and Biological Activities of β-Carboline Derivatives – An Update

  2022cites this paper
• Age and metastasis - How age influences metastatic spread in cancer. Colorectal cancer as a model.

  2022cites this paper
• Correlation Between Long-Term Acetylsalicylic Acid Use and Prostate Cancer Screening with PSA. Should We Reduce the PSA Cut-off for Patients in Chronic Therapy? A Multicenter Study

  2022cites this paper
• An Evaluation of the Inhibition Effects of Cell Migration of Aspirin Soaking 360°Square-Edge Intraocular Lens in an in Vitro Lens Capsule Model

  2021cites this paper
• EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics.

  2021cites this paper
• Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment

  2021cites this paper
• Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matched analysis

  2021cites this paper
• Association between aspirin use and lung cancer incidence depends on high-frequency use, bodyweight, and age in U.S. adults

  2021cites this paper
• Updates on the molecular mechanisms of aspirin in the prevention of colorectal cancer: Review

  2021cites this paper
• Aspirin, ibuprofen, and reduced risk of advanced colorectal adenoma incidence and recurrence and colorectal cancer in the PLCO Cancer Screening Trial

  2021cites this paper
• Implications of the growing incidence of global colorectal cancer.

  2020cites this paper
• Aspirin and the risk of nondigestive tract cancers: An updated meta‐analysis to 2019

  2020cites this paper
• The Novel Aspirin as Breakthrough Drug for COVID-19: A Narrative Review

  2020cites this paper
• Association between the use of aspirin and risk of lung cancer: results from pooled cohorts and Mendelian randomization analyses

  2020cites this paper
• Perspectives on Drug Repurposing.

  2020cites this paper
• Aspirin and its pleiotropic application.

  2020cites this paper
• Prinzipien der primären Prävention von Krebserkrankungen

  2020cites this paper
• Aspirin Modifies Inflammatory Mediators and Metabolomic Profiles and Contributes to the Suppression of Obesity-Associated Breast Cancer Cell Growth

  2020cites this paper
• Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer Cells.

  2020cites this paper
• Do Aspirin and Flavonoids Prevent Cancer through a Common Mechanism Involving Hydroxybenzoic Acids?—The Metabolite Hypothesis

  2020cites this paper
• Prostaglandin E2 as a Therapeutic Target in Bladder Cancer: From Basic Science to Clinical Trials.

  2020cites this paper
• Effects of aspirin on the gastrointestinal tract: Pros vs. cons

  2020cites this paper
• Primärprävention von Plattenepithelkarzinomen des Ösophagus und des Anus

  2020cites this paper
• LIMITATIONS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND THE UTILITY OF NATURAL PRODUCTS FOR ANTINOCICEPTIVE AND ANTIEXUDATIVE EFFECTS

  2020cites this paper
• Aspirin and the chemoprevention of cancers: A mathematical and evolutionary dynamics perspective

  2020cites this paper
• A methodology for investigating the impact of medical countermeasures on the risk of exposure induced death.

  2020cites this paper
• A Methodology for the Detection of Relevant Single Nucleotide Polymorphism in Prostate Cancer by Means of Multivariate Adaptive Regression Splines and Backpropagation Artificial Neural Networks

  2020cites this paper
• Stromal Fibroblasts Restrain the Rate of Colon Cancer Progression and Metastasis by Suppressing Regulatory T Cells and Colon Cancer Stem Cells

  2020cites this paper
• Aspirin and Reducing Risk of Gastric Cancer: Systematic Review and Meta-Analysis of the Observational Studies.

  2020cites this paper
• Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population

  2020cites this paper
• Dexibuprofen amide derivatives as potential anticancer agents: synthesis, in silico docking, bioevaluation, and molecular dynamic simulation

  2019cites this paper
• Colon cancer stem cells: Potential target for the treatment of colorectal cancer

  2019cites this paper
• Lifestyle and dietary environmental factors in colorectal cancer susceptibility.

  2019cites this paper
• Nonsteroidal anti-inflammatory drugs– What do we (not) know about them

  2019cites this paper
• Myeloid immunosuppression and immune checkpoints in the tumor microenvironment

  2019cites this paper
• Aspirin use and pancreatic cancer risk

  2019cites this paper
• The Crucial Role of CXCL8 and Its Receptors in Colorectal Liver Metastasis

  2019cites this paper
• Carrots and cancer : the bioavailability of polyacetylene from carrots and their assocation with biomarkers of cancer risk

  2019cites this paper
• Dexibuprofen amide derivatives as potential anticancer agents: synthesis, in silico docking, bioevaluation, and molecular dynamic simulation

  2019cites this paper
• Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideli

  2019cites this paper
• The Cytotoxicity and Synergistic Potential of Aspirin and Aspirin Analogues Towards Oesophageal and Colorectal Cancer

  2019cites this paper
• Therapeutic cancer prevention: achievements and ongoing challenges – a focus on breast and colorectal cancer

  2019cites this paper
• Low-dose anti-inflammatory combinatorial therapy reduced cancer stem cell formation in patient-derived preclinical models for tumour relapse prevention

  2019cites this paper
• Aspirin metabolites 2,3-DHBA and 2,5-DHBA inhibit cancer cell growth: Implications in colorectal cancer prevention

  2019cites this paper
• Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.

  2019cites this paper
• Effects of low-dose aspirin on clinical outcome and disease progression in patients with gastroenteropancreatic neuroendocrine neoplasm

  2019cites this paper
• Preventing Metachronous Gastric Cancer after the Endoscopic Resection of Gastric Epithelial Neoplasia: Roles of Helicobacter pylori Eradication and Aspirin

  2019cites this paper
• Aspirin for the primary prevention of cardiovascular disease: latest evidence

  2019cites this paper
• Aspirin suppresses tumor cell-induced angiogenesis and their incongruity

  2019cites this paper
• Aspirin Use and Lethal Prostate Cancer in the Health Professionals Follow-up Study.

  2019cites this paper
• Esophageal squamous cell cancer susceptibility: Environmental and nutritional associations reveal a universally applicable pathogenesis scenario (Review)

  2019cites this paper
• Reduced risk of cancer among low‐dose aspirin users: Data from French health care databases

  2019cites this paper
• Risk-reducing medications for primary breast cancer: a network meta-analysis.

  2019cites this paper
• Effect of Intermittent Versus Continuous Low-Dose Aspirin on Nasal Epithelium Gene Expression in Current Smokers: A Randomized, Double-Blinded Trial

  2019cites this paper
• Inhibition of the development of N-nitrosomethylbenzylamine-induced esophageal tumors in rats by strawberries and aspirin, alone and in combination

  2018influential citation
• Levothyroxine use and the risk of breast cancer: a nation-wide population-based case–control study

  2018cites this paper
• Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden

  2018influential citation
• Dietary patterns and risk of advanced colorectal neoplasms: A large population based screening study in Germany.

  2018cites this paper
• The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study

  2018cites this paper
• Chapter 5 Helicobacter pylori Infection and Gastric Cancer — Is Eradication Enough to Prevent Gastric Cancer

  2018cites this paper
• Colorectal cancer prevention: Immune modulation taking the stage.

  2018cites this paper
• Clinically Relevant Anti-Inflammatory Agents for Chemoprevention of Colorectal Cancer: New Perspectives

  2018cites this paper
• Non-hormonal Chemoprevention

  2018cites this paper
• A methodology for detecting relevant single nucleotide polymorphism in prostate cancer with multivariate adaptive regression splines and backpropagation artificial neural networks

  2018cites this paper
• The Value of Helicobacter Eradication in Long-term Aspirin Users

  2018cites this paper
• Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD)

  2018cites this paper
• Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium

  2018cites this paper
• Indomethacin from Anti-Inflammatory to Anticancer Agent

  2018cites this paper
• Does the oncology community have a rejection bias when it comes to repurposed drugs?

  2018cites this paper
• Chapter 81 – Colorectal Cancer

  2018cites this paper
• Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis

  2018cites this paper
• Population Dynamics and Evolution of Cancer Cells

  2018cites this paper
• Progress in preventive therapy for cancer: a reminiscence and personal viewpoint

  2018cites this paper
• The cXcl 12 rs 1801157 polymorphism and risk of colorectal cancer : a meta-analysis

  2018cites this paper
• Can a gastric cancer risk survey identify high-risk patients for endoscopic screening? A pilot study.

  2018cites this paper
• The CXCL12 rs1801157 polymorphism and risk of colorectal cancer: a meta-analysis

  2018cites this paper